cellectar.com cellectar.com

cellectar.com

Cellectar Biosciences | Phospholipid Drug Conjugates (PDCs) for Targeted Delivery of Oncologic Payloads

Cellectar is developing novel agents to detect, treat and monitor a broad spectrum of cancers.

http://www.cellectar.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR CELLECTAR.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.0 out of 5 with 6 reviews
5 star
0
4 star
4
3 star
0
2 star
0
1 star
2

Hey there! Start your review of cellectar.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

0.4 seconds

FAVICON PREVIEW

  • cellectar.com

    16x16

  • cellectar.com

    32x32

  • cellectar.com

    64x64

  • cellectar.com

    128x128

CONTACTS AT CELLECTAR.COM

Jamey Weichert

Jamey Weichert

3301 Ag●●●●●●●e Drive

Ma●●on , WI, 53716

US

1.60●●●●8120
1.60●●●●8121
jw●●●●●●●@cellectar.com

View this contact

Cellectar, Inc.

Neal Sandy

3301 Ag●●●●●●●e Drive

Ma●●on , WI, 53716

US

1.60●●●●8120
1.60●●●●8121
ns●●●●@cellectar.com

View this contact

Registercom

Domain Registrar

575 8●●●●●venue

New●●●ork , NY, 10018

US

1.90●●●●2701
1.90●●●●2701
do●●●●●●●●●●●●●@register.com

View this contact

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED
1999 November 23
UPDATED
2013 October 17
EXPIRATION
EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

Network Solutions®

DOMAIN AGE

  • 24

    YEARS

  • 5

    MONTHS

  • 20

    DAYS

NAME SERVERS

1
dns041.a.register.com
2
dns067.b.register.com
3
dns249.c.register.com
4
dns249.d.register.com

REGISTRAR

REGISTER.COM, INC.

REGISTER.COM, INC.

WHOIS : whois.register.com

REFERRED : http://www.register.com

CONTENT

SCORE

6.2

PAGE TITLE
Cellectar Biosciences | Phospholipid Drug Conjugates (PDCs) for Targeted Delivery of Oncologic Payloads | cellectar.com Reviews
<META>
DESCRIPTION
Cellectar is developing novel agents to detect, treat and monitor a broad spectrum of cancers.
<META>
KEYWORDS
1 our approach
2 management team
3 board of directors
4 quick facts
5 pdc delivery platform
6 posters and publications
7 pdc pipeline
8 pdc product pipeline
9 clinical trials
10 current trials
CONTENT
Page content here
KEYWORDS ON
PAGE
our approach,management team,board of directors,quick facts,pdc delivery platform,posters and publications,pdc pipeline,pdc product pipeline,clinical trials,current trials,archived trials,partnering,current partnerships,opportunities,news,investors,clint
SERVER
Apache
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Cellectar Biosciences | Phospholipid Drug Conjugates (PDCs) for Targeted Delivery of Oncologic Payloads | cellectar.com Reviews

https://cellectar.com

Cellectar is developing novel agents to detect, treat and monitor a broad spectrum of cancers.

INTERNAL PAGES

cellectar.com cellectar.com
1

PET Imaging | Cellectar BioSciences

http://cellectar.com/rd-pipeline/pet-imaging

Posters & Publications. CLR 124 Posters & Publications. CLR 1502 Posters & Publications. CLR 131 Posters & Publications. CLR 1404 Posters & Publications. Posters & Publications. Events & Presentations. CLR 124- More accurate imaging for better patient management. View Posters and Publications. 8211; Play the video. And significantly better uptake in both tumors. The “H” indicates the heart. The image on the right reflects the tremendous potential of CLR 1404 in certain malignancies such as prostate and o...

2

Posters & Publications | Cellectar BioSciences

http://cellectar.com/rd-pipeline/posters-publications

Posters & Publications. CLR 124 Posters & Publications. CLR 1502 Posters & Publications. CLR 131 Posters & Publications. CLR 1404 Posters & Publications. Posters & Publications. Events & Presentations. Posters & Publications. Alkylphosphocholine Analogs for Broad Spectrum Cancer Imaging and Therapy. Tumor-specific alkylphosphocholine analogs were evaluated as imaging and therapy agents in patients and in animal models of human cancer. Imaging In 2020 Oral Presentation Weichert UW October 2012. Relative B...

3

Optical Imaging | Cellectar BioSciences

http://cellectar.com/rd-pipeline/optical-imaging

Posters & Publications. CLR 124 Posters & Publications. CLR 1502 Posters & Publications. CLR 131 Posters & Publications. CLR 1404 Posters & Publications. Posters & Publications. Events & Presentations. CLR 1502 – Real-Time Optical Imaging for Better Surgical Outcomes. View Posters and Publications. Real Time Intraoperative Tumor Margin Illumination. 8211; Real time near infrared video of a conscious mouse walking in the imaging field of a NIR camera wherein a 2mm orthotopic brain tumor (bright spot) is v...

4

Corporate Governance | Cellectar BioSciences

http://cellectar.com/about-us/corporate-governance

Posters & Publications. CLR 124 Posters & Publications. CLR 1502 Posters & Publications. CLR 131 Posters & Publications. CLR 1404 Posters & Publications. Posters & Publications. Events & Presentations. Click to view Code of Ethics. Click to view Audit Committee Charter. Click to view Compensation Committee Charter. Click to view Nominating and Corporate Governance Committee Charter. Madison, WI 53716.

5

Advisors | Cellectar BioSciences

http://cellectar.com/about-us/advisors

Posters & Publications. CLR 124 Posters & Publications. CLR 1502 Posters & Publications. CLR 131 Posters & Publications. CLR 1404 Posters & Publications. Posters & Publications. Events & Presentations. Michael Kurman, M.D., Medical Oncology Consultant. Minesh Mehta, M.D., FASTRO, Radiation Oncology Consultant. Michael Kurman, M.D., Medical Oncology. Minesh Mehta, M.D., FASTRO, Radiation Oncology. Madison, WI 53716.

UPGRADE TO PREMIUM TO VIEW 11 MORE

TOTAL PAGES IN THIS WEBSITE

16

LINKS TO THIS WEBSITE

pennystockspost.com pennystockspost.com

Cellectar Biosciences (OTC: CLRB) This company is solid! | Penny Stocks Post

http://pennystockspost.com/cellectar-biosciences-otc-clrb-this-company-is-solid

August 31, 2016. Cellectar Biosciences (OTC: CLRB) This company is solid! Cellectar Biosciences (OTC: CLRB) This company is solid! Thursday, 27 March 2014. Cellectar Biosciences (OTC: CLRB) But will the stock price finally go up? CLICK HERE TO SIGN UP FOR OUR FREE NEWSLETTER and RECEIVE A FREE FULL REPORT ON CLRB WITH PRICE TARGET! Madison, WI 53716. Website: http:/ www.cellectar.com. CLICK HERE TO SIGN UP FOR OUR FREE NEWSLETTER and RECEIVE A FREE FULL REPORT ON CLRB WITH PRICE TARGET! A/o Mar 26, 2014.

wisinvpartners.com wisinvpartners.com

- WIP

http://www.wisinvpartners.com/home/portfolio

AquaMost - Patented water treatment system used in hydraulic fracking and other water purification applications. AquaMost develops and deploys water treatment solutions for industrial, environmental, and drinking water purification applications. AquaMost's technology, which uses no chemical feedstocks, is a clean and safe solution for treating water. BellBrook Labs, LLC develops detection reagents and microfluidic devices that accelerate the discovery of more effective therapies for cancer and other debi...

ventureinvestors.com ventureinvestors.com

Portfolio Companies – Venture Investors

http://www.ventureinvestors.com/portfolio-companies

Feature some of the leading technology innovators in the Midwest. We are proud to work closely with our technical founders and executive teams as they bring their technologies to market. Cellectar Biosciences, Inc. Aerpio Therapeutics is a pharmaceutical company spun out of Akebia Therapeutics, with programs focused on Tie2 activation for the treatment of retinopathy, vascular leak, cancer, inflammatory bowel disease and would healing. Cellectar Biosciences, Inc. Elucent Medical is a medical device compa...

UPGRADE TO PREMIUM TO VIEW 7 MORE

TOTAL LINKS TO THIS WEBSITE

10

OTHER SITES

cellect-in.com cellect-in.com

Domain ist reserviert

cellect.org cellect.org

CELLECT

Serving Information and Ingredients. Virginia Academy of Science. Please know that CELLECT™. Or any person relative to this product do not make any implications, promises, nor guarantees that CELLECT™. Will reverse any disease. The information herein is determined informational and observational. Although the observations and documentations show positive results, it is the reader’s obligation to discuss with their medical professional, and make their own decisions. Please know that CELLECT™.

cellecta.biz cellecta.biz

Commercial & Industrial Construction

Commercial and Industrial Construction. All Basics You Need to Know About Ready Mix Screed. What is Attic Screed? In the accent of a accurate specialist, a attic assize is a actual fabricated out of adhesive and aciculate beach in a 1:3 or 1:4.5 ratio. It is laid assimilate either a caked accurate attic assemblage or assimilate a solid in-situ accurate attic slab. Concrete Vs Assize – Is it One and Same? Both attic assize and accessible alloyed accurate are fabricated out of aforementioned capacity inclu...

cellecta.co.uk cellecta.co.uk

Cellecta

01634 296677 or 441634 296677. Modified Beam and Block. Light Masonry Walls Timber Floors. Ultralay 3 & 5. Batten 45 & 70. 17T, 26T & 30T. 37T & Quattro. ES & FS Flanking Strips. 12c, 21c & 28c. Brochures & Samples. Insulation Project Year Book. Code for sustainable homes. Acoustic and Thermal Insulation Manufacturers. Acoustic and Thermal Insulation Manufacturers. Acoustic and Thermal Insulation Specialists. Call Now – Acoustic and thermal insulation. 8211; 01634 296 677 – Contact Form. And acoustic res...

cellecta.com cellecta.com

RNAi and CRISPR Screening, Drug Target and Biomarker Discovery

CellTracker 50M Lentiviral Barcode Library. CellTracker Barcode Cell Labeling Kits. CRISPR Human Genome-Wide Knockout Libraries. Single-Module Human Genome-Wide CRISPR Library (80K). Three-Module Human Genome-Wide CRISPR Library (150K). CRISPRa CRISPRi Human Genome-Wide Libraries. CRISPR Mouse Genome-Wide Knockout Library. CRISPRa CRISPRi Mouse Genome-Wide Libraries. CRISPRtest Functional Cas9 Activity Kits (Mammalian). CRISPR Knockout Control Constructs. Human Genome-Wide shRNA Library. Genetic Screenin...

cellectar.com cellectar.com

Cellectar Biosciences | Phospholipid Drug Conjugates (PDCs) for Targeted Delivery of Oncologic Payloads

How to Contact Us. News & Investors. How to Contact Us. News & Investors. Create is a multi-purpose WordPress theme that gives you the power to create many different styles of websites. How to Contact Us. News & Investors. Better Therapy Through Targeted Delivery. Scroll Down For More Information). Phospholipid Drug Conjugates (PDCs). For Targeted Delivery of Oncologic Payloads. Cellectar Biosciences is developing phospholipid drug conjugates (PDCs) designed to provide cancer targeted delivery of diverse...

cellectarbiosciences.com cellectarbiosciences.com

Cellectar Biosciences | Novel Agents for the Treatment and Diagnosis of Cancer

Posters & Publications. I-124-CLR1404 Posters & Publications. CLR1502 Posters & Publications. I-131-CLR1404 Posters & Publications. CLR1404 Posters & Publications. Posters & Publications. Events & Presentations. As seen in Science Translational Medicine. Alkylphosphocholine Analogs for Broad Spectrum Cancer Imaging and Therapy. Read our latest publication in Neurosurgery. Fluorescent Cancer-Selective Alkylphosphocholine Analogs for Intraoperative Glioma Detection. I-124-CLR1404 Phase 2 Trial. Jan 22, 2015.

cellectbio.com cellectbio.com

cellect bio

Graft Versus Host Disease. Cellect Biotechnology was founded in 2011 with a mission to become a global leader in the next generation of cellular therapies by developing innovative solutions for immune system regeneration. Achieving higher selectivity, greater specificity and decreased toxicity, Cellect envisions its products becoming an integral and essential part of Bone Marrow Transplantation (BMT), as well as integrated into many aspects of regenerative medicine.

cellectbiotech.com cellectbiotech.com

Cellect Biotech™ | Coming Soon...

T 44 (0)1565 650000. F 44 (0)1565 872734. Thank you for visiting Cellect Biotech. The main website is currently being developed and will launch soon. In the meantime, here is an introduction to who we are, and what we do. In order to bring this exciting innovation to market, the two companies have just signed a joint venture agreement and formed a new company called Cellect Biotech. Please download the recent press release in pdf format for more details.

cellectbudwig.com cellectbudwig.com

cellectbudwig.com

Friday, 22.05.2015. Introduction to the Cellect-Budwig Protocol.

cellectbudwigdiet.com cellectbudwigdiet.com

Cancer Testing and Metabolic Programs